| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $103K | -46.6% |
| R&D Expense | $580K | +2.5% |
| SG&A Expense | $7.7M | -18.4% |
| Operating Income | -$8.2M | +16.5% |
| Net Income | -$8.8M | +48.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $192K | -90.8% |
| Accounts Receivable | $20K | -16.7% |
| Current Assets | $212K | -90.0% |
| Total Assets | $313K | -86.0% |
| Current Liabilities | $15.0M | +10.4% |
| Total Liabilities | $15.2M | +9.7% |
| Stockholders' Equity | -$14.0M | -30.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.3M | -39.0% |
| Capital Expenditures | $39K | — |
| Investing Cash Flow | -$39K | — |
| Financing Cash Flow | $2.4M | -51.8% |
| Free Cash Flow | -$4.3M | -40.3% |